Symbol | Definition | n | KOS/WS (vs. WS) % | WPCP/WS (vs. WS) % | KOPCP/KOS % | (vs. WPCP/WS) |
---|---|---|---|---|---|---|
Significantly changed gene expressions induced by PCP of wild-type mice | ||||||
Fos | FBJ osteosarcoma oncogene | 4 | 89 ± 7 | 271 ± 16 ** | 179 ± 5 | c |
Fosb | FBJ osteosarcoma oncogene B (Fosb) | 3 | 98 ± 7 | 246 ± 69 ** | 134 ± 19 | a |
Ddit4 | DNA-damage-inducible transcript 4 (REDD1) | 3 | 112 ± 5 | 200 ± 8 ** | 164 ± 4 | b |
Egr4 | early growth response 4 | 4 | 107 ± 19 | 164 ± 56 ** | 86 ± 3 | b |
Tsc22d3 | TSC22 domain family, member 3, transcript variant 1 (DSIPI) | 4 | 100 ± 7 | 209 ± 24 * | 190 ± 15 | a |
Gadd45g | growth arrest and DNA-damage-inducible 45 γ | 4 | 103 ± 2 | 189 ± 25 * | 146 ± 7 | a |
Cfp | complement factor properdin (Properdine) | 4 | 105 ± 19 | 151 ± 9 ** | 126 ± 20 | a |
Slc2a1 | solute carrier family 2 (GLUT1) | 4 | 93 ± 5 | 149 ± 8 ** | 150 ± 5 | a |
Txnip | thioredoxin interacting protein, transcript variant 1 | 4 | 106 ± 8 | 143 ± 16 ** | 126 ± 10 | a |
Bag-3 | Bcl2-associated athanogene 3 | 4 | 91 ± 6 | 142 ± 6 ** | 128 ± 6 | a |
Pglyrp1 | peptidoglycan recognition protein 1 (PGRP-S) | 3 | 93 ± 5 | 139 ± 12 ** | 128 ± 12 | a |
Arrdc | arrestin domain containing 3 (mKIAA1376) | 3 | 110 ± 1 | 136 ± 14 * | 115 ± 14 | a |
Rgc32 | RIKEN cDNA 1190002H23 gene | 4 | 97 ± 6 | 131 ± 7 * | 123 ± 6 | a |
Significantly changed gene expressions induced by PCP of NR2D KO mice | ||||||
Egr1 | early growth response 1(zif-268) | 4 | 94 ± 8 | 87 ± 8 | 67 ± 3 | a |